Indian J Pharm Close
 

Figure 3 :Group 3- Aq.E.PN treated group showing no vacuolated cells and myofibres loss and normal architecture (10)

Figure 3 :Group 3- Aq.E.PN treated group showing no vacuolated cells and myofibres loss and normal architecture (10)